CompletedPhase 3NCT01677910

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

Studying Carcinoid syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lexicon Pharmaceuticals
Principal Investigator
Pablo Lapuerta, MD
Lexicon Pharmaceuticals, Inc
Intervention
Telotristat etiprate(drug)
Enrollment
135 enrolled
Eligibility
18 years · All sexes
Timeline
20132016

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01677910 on ClinicalTrials.gov

Other trials for Carcinoid syndrome

Additional recruiting or active studies for the same condition.

See all trials for Carcinoid syndrome

← Back to all trials